Variant report
Variant | esv3467699 |
---|---|
Chromosome Location | chr4:152788802-152794500 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs115128166 | chr4:152788847-152788848 | Weak transcription ZNF genes & repeats Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
2 | rs186790527 | chr4:152788854-152788855 | Weak transcription ZNF genes & repeats Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
3 | rs17027984 | chr4:152788860-152788861 | Weak transcription ZNF genes & repeats Enhancers Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs547037460 | chr4:152788902-152788903 | Weak transcription ZNF genes & repeats Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
5 | rs565771829 | chr4:152788912-152788913 | Weak transcription ZNF genes & repeats Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
6 | rs539134371 | chr4:152789005-152789006 | Weak transcription Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
7 | rs17027987 | chr4:152789015-152789016 | Weak transcription Enhancers ZNF genes & repeats | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs145830456 | chr4:152789016-152789017 | Weak transcription Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
9 | rs148987316 | chr4:152789028-152789029 | Weak transcription Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
10 | rs555699661 | chr4:152789048-152789049 | Weak transcription Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
11 | rs111433340 | chr4:152789055-152789056 | Weak transcription Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
12 | rs527616863 | chr4:152789071-152789072 | Weak transcription Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
13 | rs115403575 | chr4:152789084-152789085 | Weak transcription Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
14 | rs553043791 | chr4:152789119-152789120 | Weak transcription Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
15 | rs368510875 | chr4:152789142-152789143 | Weak transcription Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
16 | rs578062998 | chr4:152789211-152789212 | Weak transcription ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs545063465 | chr4:152789262-152789263 | Weak transcription ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs545699751 | chr4:152789268-152789269 | Weak transcription ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs13109860 | chr4:152789287-152789288 | Weak transcription ZNF genes & repeats Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs73862586 | chr4:152789302-152789303 | Weak transcription ZNF genes & repeats Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs191449527 | chr4:152789314-152789315 | Weak transcription ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs542960546 | chr4:152789372-152789373 | Weak transcription ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs17027990 | chr4:152789393-152789394 | Weak transcription ZNF genes & repeats Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs148167184 | chr4:152789412-152789413 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs76531070 | chr4:152789434-152789435 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs141523860 | chr4:152789463-152789464 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs361168 | chr4:152789474-152789475 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs73862587 | chr4:152789483-152789484 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs75744111 | chr4:152789505-152789506 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs184760032 | chr4:152789507-152789508 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs140085551 | chr4:152789519-152789520 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs145284651 | chr4:152789534-152789535 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs567552736 | chr4:152789543-152789544 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs187962169 | chr4:152789644-152789645 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs368006248 | chr4:152789647-152789648 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs553349509 | chr4:152789665-152789666 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs137928154 | chr4:152789712-152789713 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs192848313 | chr4:152789713-152789714 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs72732124 | chr4:152789729-152789730 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
40 | rs185219214 | chr4:152789746-152789747 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs542815413 | chr4:152789758-152789759 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs165581 | chr4:152789786-152789787 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
43 | rs573495375 | chr4:152789828-152789829 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs142485766 | chr4:152789835-152789836 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs9994589 | chr4:152789836-152789837 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs190146162 | chr4:152789842-152789843 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs181337820 | chr4:152789874-152789875 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs112748677 | chr4:152789891-152789892 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs532316551 | chr4:152789907-152789908 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs549223660 | chr4:152789910-152789911 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 21183584 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Breast cancer | 16272173 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Breast cancer | 21785460 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Breast cancer | 21633010 | CNVD |
Breast cancer | 21364760 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Breast cancer | 17588203 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Melanoma | 20877625 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:152780800-152789000 | Enhancers | Fetal Brain Male | brain |
2 | chr4:152781200-152794800 | Weak transcription | H9 Cell Line | embryonic stem cell |
3 | chr4:152785200-152789400 | Enhancers | Primary monocytes fromperipheralblood | blood |
4 | chr4:152786000-152789000 | Enhancers | Primary neutrophils fromperipheralblood | blood |
5 | chr4:152786000-152789000 | Flanking Active TSS | Monocytes-CD14+_RO01746 | blood |
6 | chr4:152786200-152789200 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
7 | chr4:152787600-152789000 | Enhancers | Dnd41 | blood |
8 | chr4:152788200-152789200 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
9 | chr4:152788600-152789200 | ZNF genes & repeats | Pancreas | Pancrea |
10 | chr4:152788800-152789000 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |
11 | chr4:152788800-152789000 | Enhancers | Primary Natural Killer cells fromperipheralblood | blood |
12 | chr4:152789000-152789400 | Enhancers | Monocytes-CD14+_RO01746 | blood |
13 | chr4:152789000-152791200 | Weak transcription | Fetal Brain Male | brain |
14 | chr4:152789000-152796200 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
15 | chr4:152789200-152789400 | ZNF genes & repeats | ES-UCSF4 Cell Line | embryonic stem cell |
16 | chr4:152789400-152793800 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
17 | chr4:152791200-152791400 | Enhancers | Fetal Brain Male | brain |
18 | chr4:152791400-152800200 | Weak transcription | Fetal Brain Male | brain |
19 | chr4:152793800-152794000 | ZNF genes & repeats | ES-UCSF4 Cell Line | embryonic stem cell |
20 | chr4:152793800-152794000 | Enhancers | Thymus | Thymus |
21 | chr4:152794000-152794400 | Weak transcription | Aorta | Aorta |
22 | chr4:152794000-152795000 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |